We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
-$208K
Cap. Flow
+$2.42M
Cap. Flow %
1.71%
Top 10 Hldgs %
51.56%
Holding
51
New
6
Increased
20
Reduced
15
Closed
5

Top Buys

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$2.43M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$2.39M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$2.29M
4
BPMC
Blueprint Medicines
BPMC
+$2.27M
5
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$2.27M

Top Sells

Rank Stock Value
1
SLDB icon
Solid Biosciences
SLDB
+$2.75M
2
ARGX icon
argenx
ARGX
+$2.35M
3
ATNX
Athenex, Inc. Common Stock
ATNX
+$2.31M
4
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$2.21M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$2.14M

Sector Composition

Rank Sector Weight
1 Healthcare 50.39%
2 Financials 32.94%
3 Consumer Discretionary 8.74%
4 Industrials 2.71%
5 Real Estate 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
26
Ascendis Pharma A/S
ASND
$16.7B
$2.11M 1.49%
18,334
-14,143
-44% -$1.69M
GBT
27
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.07M 1.46%
39,349
-6,422
-14% -$369K
THOR
28
DELISTED
Synthorx, Inc. Common Stock
THOR
$2.04M 1.44%
151,048
+31,313
+26% +$502K
C icon
29
Citigroup
C
$222B
$2.03M 1.43%
28,938
-1,089
-4% -$72.9K
CBRE icon
30
CBRE Group
CBRE
$40.8B
$2M 1.41%
39,052
+486
+1% +$24.2K
STX icon
31
Seagate
STX
$193B
$1.99M 1.4%
42,275
+56
+0.1% +$2.61K
BHC icon
32
Bausch Health
BHC
$1.65B
$1.97M 1.39%
78,121
+2,293
+3% +$54.4K
ACA icon
33
Arcosa
ACA
$7.12B
$1.97M 1.38%
52,264
-9,078
-15% -$310K
KKR icon
34
KKR & Co
KKR
$89.2B
$1.94M 1.37%
76,943
-5,098
-6% -$122K
MS icon
35
Morgan Stanley
MS
$337B
$1.9M 1.34%
43,300
-2,664
-6% -$119K
RYTM icon
36
Rhythm Pharmaceuticals
RYTM
$7B
$1.9M 1.34%
86,208
+6,810
+9% +$172K
TRN icon
37
Trinity Industries
TRN
$2.97B
$1.88M 1.32%
90,599
+14,830
+20% +$316K
SLM icon
38
SLM Corp
SLM
$4.58B
$1.85M 1.31%
190,827
+20,798
+12% +$206K
BFH icon
39
Bread Financial
BFH
$4.21B
$1.83M 1.29%
16,324
+2,363
+17% +$286K
ORTX
40
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.73M 1.21%
12,340
-3,300
-21% -$579K
MYOV
41
DELISTED
Myovant Sciences Ltd.
MYOV
$1.61M 1.13%
177,988
+66,063
+59% +$985K
SMC
42
Summit Midstream
SMC
$421M
$651K 0.46%
5,837
– –
HD icon
43
Home Depot
HD
$332B
$378K 0.27%
+1,819
New +$363K
COCP icon
44
Cocrystal Pharma
COCP
$12.4M
$359K 0.25%
12,743
– –
SPY icon
45
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$276K 0.19%
942
– –
IFRX icon
46
InflaRx
IFRX
$256M
$185K 0.13%
58,449
-13,435
-19% -$425K
ARGX icon
47
argenx
ARGX
$57.4B
– –
-18,819
Closed -$2.35M
CRNX icon
48
Crinetics Pharmaceuticals
CRNX
$8.86B
– –
-97,035
Closed -$2.21M
SLDB icon
49
Solid Biosciences
SLDB
$771M
– –
-19,926
Closed -$2.75M
ATNX
50
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-9,435
Closed -$2.31M
1
2
3

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q2 2019 Portfolio in Review

As of Q2 2019, Emory University held 51 positions worth $142M, down 0.15% from $142M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Emory University's Q2 2019 filing shows 6 new, 20 increased, 15 reduced and 5 closed positions. Its largest new stake was Array Biopharma Inc: 86,567 shares worth $4.01M. The largest sale was Solid Biosciences, an estimated $2.75M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 53% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Emory University's largest Q2 2019 buy was Array Biopharma Inc: 86,567 shares worth $4.01M.
  • Emory University added most to BioCryst Pharmaceuticals in Q2 2019, an estimated $2.29M increase.
  • Emory University's biggest Q2 2019 reduction was Ascendis Pharma A/S, cutting an estimated $1.69M.
  • Emory University fully exited Solid Biosciences in Q2 2019, selling an estimated $2.75M.
  • Emory University's ten largest holdings make up 52% of its $142M portfolio in Q2 2019.
  • Emory University opened 6 new positions and closed 5 in Q2 2019.
  • Emory University's portfolio value fell 0.15% quarter-over-quarter to $142M.

Based on Emory University's 13F filing for Q2 2019, filed 14 Aug 2019.